Lv4
670 积分 2022-09-11 加入
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
3个月前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
3个月前
已完结
A distinct population of CD8+ T cells expressing CD39 and CD73 accumulates with age and supports cancer progression
5个月前
已完结
IKZF3 Overexpression Phenocopies Gain-of-Function Mutation in Chronic Lymphocytic Leukemia
皖公网安备34019202002308
